newsfilter
← Latest News
PR Newswire·

IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences

  • IDEAYA Biosciences announced an Investor R&D Day in London on November 16, 2026, at 5:00 PM GMT featuring Dr. Frank McCormick.
  • The London event will cover MTAP/CDKN2A & KRAS development strategies in pancreatic cancer, new preclinical data, & combination strategies for tumor heterogeneity.
  • Registration is required for both in-person & virtual attendance at the London event via the provided link.
  • CEO Yujiro S. Hata will participate in fireside chats at the Wells Fargo Healthcare Conference on September 8, 2026, with CFO Joshua Bleharski.
  • CEO Yujiro S. Hata will attend the Cantor Global Healthcare Conference on September 9, 2026, in New York.
  • CEO Yujiro S. Hata & CFO Joshua Bleharski will present at Citi's Biopharma Back to School Conference on September 10, 2026, in New York.
  • CEO Yujiro S. Hata will attend the Morgan Stanley Global Healthcare Conference on September 14, 2026, in New York.
  • Live audio webcasts & 30-day replays will be available on the IDEAYA investor relations website & through conference hosts.
  • IDEAYA is a precision medicine oncology company focused on small-molecule drugs, ADCs, & synthetic lethality for solid tumors.
  • The press release includes forward-looking statements regarding event plans, data presentations, & potential business outcomes.